Avoidance of treatment interruption: An unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 1, 1999, Pages 41-45

  Allal, Abdelkarim S ^a   De Pree, Christian ^a   Dulguerov, Pavel ^a   Bieri, Sabine ^a   Maire, Daphné ^a   Kurtz, John M ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Accelerated radiotherapy; Oropharynx carcinomas; Treatment interruption

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 0032777086     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00138-8     Document Type: Article

References (12)

1. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation compared to conventional fractionation improves loco-regional control in the radiotherapy of advanced head and neck cancers Results of the EORTC 22851 randomized trial . Radiother Oncol. 44:1997;111-121.
2. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy . Radiother Oncol. 25:1992;231-241.
3. Bataini J.P., Asselain B., Jaulerry C., et al. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region Clinical and treatment parameters as prognostic factors . Radiother Oncol. 14:1989;265-277.
4. Fowler J.F., Lindstrom M.J. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 23:1992;457-467.
5. Dische S., Saunders M., Barrett A., et al. A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
6. Allal A.S., Bieri S., Miralbell R., et al. Feasibility and outcome of a progressively accelerated concomitant boost radiotherapy schedule for head and neck carcinomas. Int J Radiat Oncol Biol Phys. 38:1997;685-689.
7. Allal A.S., Miralbell R., Pipard G., et al. Early and long-term results of an original accelerated radiation therapy schedule in head and neck carcinoma. Acta Oncol. 36:1997;267-271.
8. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
9. Cox D.R. Regression models and life-tables. J R Stat Soc B. 34:1972;187-220.
10. Fowler J.F. How worthwhile are short schedules in radiotherapy? A series of exploratory calculations [see comments]. Radiother Oncol. 18:1990;165-181.
11. Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.
12. Harari P.M., Fowler J.F. Idealized versus realized overall treatment times. Int J Radiat Oncol Biol Phys. 29:1994;209-211.